VEGFA and colorectal carcinoma: The study successfully achieved actively targeted accumulation of CRC tissues in a CRC model by combining nanoparticles with VEGF antibodies, and significant imaging contrast effects were observed by MRI, demonstrating the great potential of anti-VEGF-NPs as molecularly-targeted tumor developers for MRI [57].